Clinical trials · Philadelphia, PA
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 clinical trials in Philadelphia
We’re tracking 4 recruiting stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 studies with a site in or near Philadelphia — including Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Philadelphia
- NCT07195734RecruitingPhase 2
Adding chemo or immunotherapy before surgery for advanced head and neck cancer
This trial tests whether giving chemotherapy or chemotherapy plus immunotherapy before surgery can improve outcomes for people with advanced head and neck cancer that has come back or not gone away after prior treatment.
Philadelphia, PennsylvaniaAges 18 years+ - NCT02734537RecruitingPhase 2
Radiation with or without cisplatin after head and neck surgery
This trial studies whether adding cisplatin (a chemotherapy medicine) to radiation therapy helps people with stage III–IVA squamous cell cancer of the head and neck after they’ve had surgery. It’s meant to lower the risk of the cancer coming back.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05136196RecruitingPhase 2
Cabozantinib plus nivolumab for advanced melanoma or head-neck cancer
This trial tests whether combining two immunotherapy medicines—cabozantinib and nivolumab—can shrink advanced melanoma or certain head-and-neck squamous cell cancers. It is mainly for people whose cancer has grown after prior PD-1 treatment.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07441681RecruitingPhase 3
Comparing radiation plus targeted therapy vs standard chemo for head and neck cancer
This trial compares two treatments for advanced head and neck cancer in patients who cannot take the drug cisplatin. One group gets radiation plus a targeted drug called cetuximab, the other gets radiation plus standard chemotherapy. The goal is to see which approach works better and is safer for people who are not candidates for cisplatin.
Chadds Ford, PennsylvaniaAges 18 years+
Hear when a new Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 trial opens near Philadelphia, PA
We’ll email you when one opens near Philadelphia, PA — at most once a week, no account needed, unsubscribe anytime.
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 trials in other cities
Where these studies are running near Philadelphia
Institutions with a site for the recruiting stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 studies listed above.
- Helen F Graham Cancer Center · 3 studies
- Medical Oncology Hematology Consultants PA · 3 studies
- Thomas Jefferson University Hospital · 3 studies
- Asplundh Cancer Pavilion · 2 studies
- Christiana Care Health System-Christiana Hospital · 2 studies
- Christiana Care Health System-Concord Health Center · 2 studies
- Christiana Care Health System-Wilmington Hospital · 2 studies
- Cooper University Health Care
What taking part in a stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 studies in Pennsylvania.
Common questions
- Are there stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 clinical trials near Philadelphia?
- Yes. We're currently tracking 4 recruiting stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 studies with a site near Philadelphia, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 study near Philadelphia?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Philadelphia to take part?
- Not necessarily. These studies have a site near Philadelphia, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 studies open near Philadelphia regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.